Atea Pharmaceuticals Presents New Data Supporting the Fixed-Dose Combination of ...

Ruzasvir has demonstrated highly potent and pan-genotypic antiviral activity in preclinical (picomolar range) and clinical studies. Ruzasvir has been administered to over 2,100 subjects at daily doses ...

NYU Langone Cardiologists Share Leading Research at AHA Scientific Sessions 2025 & Dr ...

Expert researchers and clinicians from the Leon H. Charney Division of Cardiology at NYU Langone will present ...
Kauppalehti

T-knife Therapeutics Presents Preclinical Data on PRAME-Targeted TK-6302 Highlighting its ...

Palvelussamme on juuri nyt häiriö, yritäthän myöhemmin uudelleen. Pahoittelemme aiheutunutta haittaa.

AlphaTON Capital: Complete Tumor Regressions Observed in Preclinical Models with Co ...

AlphaTON Capital Corp (Nasdaq: ATON) ("AlphaTON") and its wholly owned oncology subsidiary Tarus Therapeutics, LLC, operating as Cyncado Therapeutics ("Cyncado") ...

Rivus Pharmaceuticals Announces New Data from Phase 2 M-ACCEL Trial of HU6 in MASH in Late ...

Trial met primary endpoint, with statistically significant reductions in liver fat observed in all HU6 treatment groups –– In addition to ...
Scientific Research Publishing

Next-Generation Cyber Defense: AI-Powered Predictive Analytics for National Security and ...

Awurum, N.P. (2025) Next-Generation Cyber Defense: AI-Powered Predictive Analytics for National Security and Threat Resilience. Open Access Library Journal, 12, 1-17. doi: 10.4236/oalib.1114210 .